Vision2Voice Joins PAO Action Week™ to Support Patient Advocacy

Vision2Voice (V2V) is proud to participate in Patient Advocacy Organization (PAO) Action Week™ from June 9–13.

Founded by Astellas Pharma Inc., PAO Action Week celebrates the vital work of Patient Advocacy Organizations—more than 1,200 U.S. nonprofits that amplify the voices, needs, and rights of patients, particularly those living with serious illnesses. Now in its second year, PAO Action Week aims to raise awareness of the support, resources, and access to treatments and research that PAOs offer patients and caregivers.

“From day one, patients have been at the center of everything we do at V2V,” said Daniel Rehal, president and founder. “Supporting PAO Action Week aligns with our mission—it’s a powerful reminder that patients deserve the best care possible. This initiative reinforces the importance of advocacy in driving meaningful change in patient care.”

At V2V, improving patient lives is more than a goal; it’s our purpose. Together, we can make a meaningful difference—one person at a time. To learn more about PAO Action Week, including how to connect with a Patient Advocacy Organization, visit paoactionweek.com.

Recent Posts

Man in suit holding back dominos

Will Your Launch Strategy Succeed or Fail?

The Challenge: A Faster, More Complex Launch Environment In today’s pharmaceutical market, strong science is the foundation, but it doesn’t always guarantee a successful launch....

Read More
Story 2

Industry Insights – June 2026

From evolving China deal dynamics and prolonged job searches to the growing push for AI-driven drug repurposing, explore how shifts in BioPharma are redefining innovation,...

Read More
FDA Commissioner Marty Makary, M.D.

Industry Insights – May 2026

Biosimilars are gaining U.S. momentum even as patent thickets keep triggering legal fights, small biotechs are feeling the pressure of the FDA’s faster-moving approval environment,...

Read More